Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Mar 1, 2025
    Senators Reintroduce Bill That Would Regulate Influencers’ Drug Posts
  • Feb 12, 2025
    Senators Ask FDA To Review Compounder’s Super Bowl Ad
  • Jan 28, 2025
    Congress Reintroduces Bills To Require Price Disclosures in DTC Ads
  • Jan 10, 2025
    FDA Issues ‘Safe Harbor’ Guidance on Providing SIUU Info to Health Care Providers
  • Jan 5, 2025
    Senators Want Payments to Advocacy Organizations Made Public
  • Dec 18, 2024
    McKinsey To Pay $650 Million To Resolve Liability for Consulting Work Performed for Purdue Pharma
  • Dec 10, 2024
    Public Citizen Asks FTC To Examine Dr. Oz’s iHerb Social Media Posts
  • Nov 25, 2024
    Trump Names Dr. Marty Makary To Lead FDA
  • Nov 15, 2024
    OPDP Issues Untitled Letter Over Instagram Post
  • Nov 1, 2024
    CBO Finds Eliminating or Limiting DTC Ads Would Result in Very Small Reductions in Drug Prices
  • More

Good Clinical Practice

  • Jan 17, 2025
    FDA Provides Guidance for Five Clinical Trial Issues
  • Jan 8, 2025
    Athira To Pay Over $4 Million To Resolve False Claims Allegations Stemming From Research Misconduct
  • Dec 29, 2024
    FDA Draft Guidance Defines ‘Important’ Protocol Deviations and Provides Recommendations for Handling Them
  • Dec 14, 2024
    FDA Details Confirmatory Trials for Accelerated Approval Drugs
  • Dec 5, 2024
    Sponsor, Investigator Receive BIMO Warning Letters
  • Nov 25, 2024
    Trump Names Dr. Marty Makary To Lead FDA
  • Nov 22, 2024
    FDA Debars Trial Center Owner and Employee
  • Nov 15, 2024
    National Academies Report Finds Use of Race and Ethnicity in Research Needs Reevaluation
  • Nov 12, 2024
    SACHRP Examines Equivalent Protections in Foreign Trials, Completes Work on Uninformative Research
  • Nov 5, 2024
    FDA Sends Warning Letters to Investigator, IRB
  • More

U.S. Food Labeling

  • Dec 6,2024
    FDA, FSIS Want Information on Food Date Labeling
  • Nov 29,2024
    FSIS Sets Jan. 1, 2028, as Next Uniform Compliance Date for New Labeling Regs
  • Nov 27,2024
    Appeals Court Upholds Dismissal of Complaint Alleging Fruit Cup Labeling Was False
  • Nov 25,2024
    Trump Names Dr. Marty Makary To Lead FDA
  • Nov 9,2024
    FDA Looks To Update ‘Healthy’ Claim, Propose FOP Labeling in FY 2025
  • Oct 25,2024
    Senate HELP Committee To Examine FOP Labeling
  • Oct 8,2024
    California To Standardize Quality, Safety Date Wording on Food Labels in 2026
  • Sep 10,2024
    FSIS Updates Substantiation Guidance for Animal-Raising and Environmental Label Claims
  • Aug 27,2024
    FDA Promises FOPL NPRM in October, Final Rule on ‘Healthy’ Definition in September
  • Aug 23,2024
    FDA Moves to Phase II of Its Sodium Reduction Program
  • More

FDA Regulation & Enforcement

  • Nov 26, 2025
    Researchers Examine Effect of Calorie Information in FOP Labels
  • Nov 21, 2025
    Study Finds Influencers’ Drug Social Media Posts Lack Risk Info and Disclosures
  • Nov 19, 2025
    Aesculap Implant Systems Enters Into $38.5M False Claims Settlement, Non-Prosecution Agreement
  • Nov 19, 2025
    OPDP Posts Three Untitled Letters
  • Nov 12, 2025
    Jury Finds for Novo Nordisk on False Claims Allegations Linked to Off-Label Marketing, Kickbacks
  • Nov 11, 2025
    New York Assembly Considers Gift Disclosure Bill
  • Nov 7, 2025
    Appeals Court Remands USDA GMO Disclosure Regs
  • Nov 6, 2025
    Janssen Challenges ‘Astronomical’ $1.64 Billion False Claims Judgment as Unconstitutional
  • Nov 3, 2025
    Group Offers Non-UPF Certification Program
  • Oct 29, 2025
    CEO Avoids Prison Time for Misbranding Conviction Linked to Devices’ Blood Lead Level Reading Errors
  • More

Medical Devices

  • Jun 18, 2025
    Claims Brought by Patient for Damages Related to IUD That Had Migrated to Her Abdomen Are Dismissed
  • Jun 11, 2025
    Under Proposed Legislation, Medicare, Medicaid Would Cover Prescription Digital Therapeutics
  • Jun 4, 2025
    Consent Decree Allows Evaluation of Company’s Claims That Products Are Devices, Not Unapproved Drugs
  • Jun 4, 2025
    FDA Outlines Pathways for Device Feedback in Finalized Guidance, Launches Pre-Sub eSTAR Submissions
  • May 26, 2025
    FDA Bans Use of Device Study Data From a Second Chinese Testing Facility in Premarket Submissions
  • May 21, 2025
    Device Firm CEO Pleads Guilty to Charge of Making False Statements to CMS Regarding Alleged Kickbacks
  • May 14, 2025
    FDA, HHS Launch Deregulation Initiative, Seek Public Input on Outdated, Unneeded Rules, Guidance
  • May 7, 2025
    FDA Is Sued Along With Boston Scientific Over Allegedly Faulty Spinal Cord Stimulator Device
  • Apr 30, 2025
    State Law Claims Brought by Survivors of Victim of Faulty ICD Dismissed on Preemption Grounds
  • Apr 23, 2025
    AdvaMed Urges Congress, Federal Agencies To Ensure Patient Access to AI-Enabled Medical Devices
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.